Sort
39,280 grants matching “leukemia”
Blood Stem Cell Transplantation as Immunotherapy
$1,882,757Samuel Strober · Stanford University · P01 · FY2010 · HL
Blood Stem Cell Transplantation as Immunotherapy
$1,882,757Samuel Strober · Stanford University · P01 · FY2012 · HL
Blood Stem Cell Transplantation as Immunotherapy
$1,882,757Samuel Strober · Stanford University · P01 · FY2011 · HL
SPORE in Myeloid Malignancies
$1,881,692Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Bioactive small molecule development
$1,881,569Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Project 1: Enabling innate-adaptive immune crosstalk by improving NK cell trafficking and resistance to suppression
$1,879,957Dean A Lee · Research Inst Nationwide Children'S Hosp · U54 · FY2019 · CA
Etiology of Alkylator-Induced Myeloid Leukemia
$1,879,357Michelle M Le Beau · University Of Chicago · P01 · FY2010 · CA
Complexity, Cooperation and Community in Cancer
$1,879,083John Lowengrub · University Of California-Irvine · U54 · FY2022 · CA
Mixed Hematopoietic Chimerism after Stem Cell Allografts
$1,876,346Fred Hutchinson Cancer Research Center · P01 · FY2004 · CA
University of New Mexico Cancer Center Support
$1,876,081Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2014 · CA
Pathophysiology and Treatment of Fanconi Anemia
$1,875,381Markus Grompe · Oregon Health & Science University · P01 · FY2016 · HL
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
$1,874,598Oliver W. Press · Fred Hutchinson Cancer Research Center · P01 · FY2006 · CA
Molecular Profiling of Clinical Specimens
$1,874,339Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Development of Novel Therapeutic Strategies in Human Leukemias
$1,868,170Benjamin Levine Ebert · Dana-Farber Cancer Inst · P01 · FY2024 · CA
Childhood Cancer Gene Program Project Grant
$1,867,761St. Jude Children'S Research Hospital · P01 · FY2004 · CA
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$1,865,407Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
$1,865,350Oliver W. Press · Fred Hutchinson Cancer Research Center · P01 · FY2007 · CA
Creating a Catalog of Cancer Clonotype Drug Sensitivities with Single-CellGenome Sequencing
$1,863,814Charles Gawad · Stanford University · DP2 · FY2018 · CA
HTS enabled examination of drug combinations
$1,863,560Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Bioactive small molecule development
$1,863,560Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Southeast Cancer Control Consortium, Inc
$1,860,642James Norman Atkins · Southeast Clinical Oncol Res Consortium · U10 · FY2007 · CA
Studies of Occupational Cancer
$1,860,441Qing Lan · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Genetic Analysis of T-cell Differentiation
$1,859,984Remy Bosselut · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Complexity, Cooperation and Community in Cancer
$1,859,909John Lowengrub · University Of California-Irvine · U54 · FY2019 · CA
GVL without GVHD across HLA barriers: Translational Studies
$1,859,788Megan Sykes · Massachusetts General Hospital · P01 · FY2008 · CA